Product Information
DORZOLAMIDE HCL 2% EYE DROPS is a generic product labeled by Somerset Therapeutics, LLC, priced at $0.8348 per ML under NDC 70069050101. Its NADAC has been published 79 times since Apr 2, 2025.
FDA first approved this application on Feb 11, 2025. Its Orange Book therapeutic-equivalence code is AT.
Strength
20 mg/mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069050101
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215004FDA Approved
2/11/2025
TE Code
AT
On Market Since
2/12/2025
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE HCL 2% EYE DROPS has been published 79 times since Apr 2, 2025, and over the history we have for it it has declined 36.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8348 per ML |
|---|---|
| All-time high | $1.4058 (Jun 11, 2025) |
| All-time low | $0.8212 (Jul 22, 2026) |
| 52-week high | $0.9950 |
| 52-week low | $0.8212 |
| Median price | $0.9254 |
| Average price | $1.0134 |
| Largest weekly change | -11.5% (Aug 20, 2025) |
| Weeks tracked | 79 |
| Tracking since | Apr 2, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dorzolamide Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carbonic Anhydrase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DORZOLAMIDE HCL 2% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE HCL 2% EYE DROPS, manufactured by Somerset Therapeutics, LLC, is $0.8348 per ML (NDC 70069050101), effective Sep 30, 2026.
How has the price of DORZOLAMIDE HCL 2% EYE DROPS changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has declined 36.5%. It has been tracked across 79 weekly CMS publications since Apr 2, 2025.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE HCL 2% EYE DROPS?
Since Apr 2, 2025, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has ranged from a low of $0.8212 (Jul 22, 2026) to a high of $1.4058 (Jun 11, 2025), with a median of $0.9254 per ML.
Are there cheaper alternatives to DORZOLAMIDE HCL 2% EYE DROPS?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DORZOLAMIDE HCL 2% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures DORZOLAMIDE HCL 2% EYE DROPS?
DORZOLAMIDE HCL 2% EYE DROPS (NDC 70069050101) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.